Filter Results:
(603)
Show Results For
- All HBS Web
(1,026)
- People (4)
- News (249)
- Research (603)
- Events (7)
- Multimedia (24)
- Faculty Publications (393)
Show Results For
- All HBS Web
(1,026)
- People (4)
- News (249)
- Research (603)
- Events (7)
- Multimedia (24)
- Faculty Publications (393)
Sort by
- 07 Aug 2007
- First Look
First Look: August 7, 2007
and issues around current practices. Purchase this note: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=807124 U.S. Food and Drug Administration Harvard Business School Note 807-050 Describes the U.S. FDA with particular... View Details
Keywords: Martha Lagace
- 21 Jul 2015
- First Look
First Look: July 21, 2015
new drug markets. Download working paper: https://www.hbs.edu/faculty/Pages/item.aspx?num=49384 Cases & Course Materials Harvard Business School Case 715-438 The Transformation of NCR During his tenure as CEO since 2005, Bill Nuti... View Details
Keywords: Sean Silverthorne
- 11 May 2010
- First Look
First Look: May 11
rapid evolution of the biopharmaceutical industry. In the early 2000s, as Millennium's competitive advantage in early-stage research slipped away and its losses mounted, founder and CEO Mark Levin moved the firm downstream away from research and towards View Details
Keywords: Martha Lagace
- 13 Jul 2009
- Research & Ideas
Diagnosing the Public Health Care Alternative
of its inadequate payments. In the end, the Democrats' health care reform will require drastic rationing of health care for the sick to control its costs. The government-controlled UK health care system points the way because it features, for example, the lowest uptake... View Details
- 02 Jul 2001
- Research & Ideas
Ray A. Goldberg
"Transforming Life, Transforming Business: The Life-Science Revolution," a McKinsey Award-winning article he coauthored in the March-April 2000 issue of Harvard Business Review. "As distinctions between food and medicine fade, we will see a proliferation... View Details
- 30 Oct 2007
- First Look
First Look: October 30, 2007
Changing Context of Pharmaceutical Risk Mitigation Author:Arthur A. Daemmrich Periodical:Pharmacy in History 49, no. 2 (2007): 61-75 Abstract In the wake of Vioxx, Avandia, and other recent prominent cases of drugs found to cause side... View Details
Keywords: Sean Silverthorne
- 22 Aug 2006
- First Look
First Look: August 22, 2006
805-067 Molecular Insight has developed a novel biopharmaceutical to detect heart attacks. The company's unique approach to intellectual property protection uses the Hatch Waxman Act and the Orphan Drug Act. The company is struggling to... View Details
Keywords: Martha Lagace
- 17 Sep 2001
- Research & Ideas
Why E-commerce Didn’t Die With the Fall of Webvan
drugs for chronic conditions—from pharmacies to a combination of direct mail and telephone. The idea was that if you have a chronic condition, you're in a replenishment mode. You have to fill the prescription regularly over a number of... View Details
- 06 May 2008
- First Look
First Look: May 6, 2008
Fibrosis Foundation: Venture Philanthropy Funding for Biotech Harvard Business School Case 808-005 In 2001, Vertex Pharmaceuticals Incorporated acquired the San Diego-based biotech company, Aurora Biosciences. The combination of Vertex's and Aurora's technologies would... View Details
Keywords: Martha Lagace
- 17 Nov 2008
- Research & Ideas
Decoding the Artful Sidestep
There are two findings that we find most interesting. First, it is striking that participants failed to punish the speaker when he dodged the question asked. For example, the speaker paid no price for answering a question about the illegal View Details
Keywords: by Martha Lagace
- 12 May 2008
- Research & Ideas
Accounting Information as Political Currency
information standards in accounting (through the Financial Accounting Standards Board) and in food labeling (through the Food and Drug Administration). There are likely lessons for both regulatory agencies in such a comparative analysis. View Details
Keywords: by Martha Lagace
- 01 May 2007
- First Look
First Look: May 1, 2007
face major challenges including headline-grabbing litigation, imminent patent expirations, new technologies, rising drug development costs, generic drug substitution, international competitors, and complex... View Details
Keywords: Sean Silverthorne
- 27 Jan 2003
- Research & Ideas
New Cluster Mapping Project Helps Companies Locate Facilities
A: There is some heartening progress. The word is out among retailers about the under-served market in inner cities. Drug chains, such as Walgreen's, and many other retailers, such as Home Depot, are pursuing this opportunity to good... View Details
Keywords: by Sean Silverthorne
- 19 Jun 2013
- Research & Ideas
Analyzing Institutions to Solve Big Problems
that marijuana was a popular treatment in the nineteenth century, and the drug was listed in the Dispensatory of the United States by the 1850s. The paper looks at how the Federal Bureau of Narcotics managed not only to illegalize the... View Details
Keywords: by Carmen Nobel & Anna Secino
- 23 Aug 2010
- Research & Ideas
The Drive to Acquire’s Impact on Globalization
inherently abusive; the citizens of the developed country are winners and the citizens of the undeveloped country may be getting a better or cheaper product. But when regulation is weak or nonexistent, this system can lend itself to severe abuse, as in the sale of fake... View Details
Keywords: by Paul R. Lawrence
- 04 Aug 2009
- First Look
First Look: August 4
to second-line drug regimens, 3.8% had died, and only one patient had been lost to follow up. A costing analysis done by the Clinton HIV/AIDS Initiative suggested that the model could feasibly be spread to other districts. Dr. Agnes... View Details
Keywords: Martha Lagace
- 02 Aug 2004
- Research & Ideas
Health Care Research and Prospects
series on AIDS in Africa and how pharmaceutical companies should think about the issues and how they might respond. Sandra Sucher has done a really wonderful case on Gleevec, which is a drug for treating chronic myeloid leukemia. She is... View Details
- 23 May 2019
- Book
These Entrepreneurs Take a Pragmatic Approach to Solving Social Problems
In 1908, Harvard Business School’s first dean, Edwin Francis Gay, welcomed the School’s inaugural class of 59 students by saying that HBS was challenged with encouraging its students to have the “intellectual respect for business as a profession, with the social... View Details
- 15 Apr 2014
- First Look
First Look: April 15
from the U.S. Food and Drug Administration (FDA) ordering the company to halt the sale and promotion of its genetic testing kit. The FDA stated that the product was marketed as a diagnostic and preventative tool and that it was subject to... View Details
Keywords: Sean Silverthorne
- 17 Oct 2012
- Research & Ideas
America Needs a Manufacturing Renaissance
sciences that laid the institutional foundations for innovations in semiconductors, high-speed computers, computer graphics, broadband communications, mobile telephony, the Internet, and modern genomics-based methods of drug discovery.... View Details